Transforming neurodegenerative disorder care with machine learning: Strategies and applications.

Journal: Neuroscience
PMID:

Abstract

Neurodegenerative diseases (NDs), characterized by progressive neuronal degeneration and manifesting in diverse forms such as memory loss and movement disorders, pose significant challenges due to their complex molecular mechanisms and heterogeneous patient presentations. Diagnosis often relies heavily on clinical assessments and neuroimaging, with definitive confirmation frequently requiring post-mortem autopsy. However, the emergence of Artificial Intelligence (AI) and Machine Learning (ML) offers a transformative potential. These technologies can enable the development of non-invasive tools for early diagnosis, biomarker identification, personalized treatment strategies, patient subtyping and stratification, and disease risk prediction. This review aims to provide a starting point for researchers, both with and without clinical backgrounds, who are interested in applying ML to NDs. We will discuss available data resources for key diseases like Alzheimer's and Parkinson's, explore how ML can revolutionize neurodegenerative care, and emphasize the importance of integrating multiple high-dimensional data sources to gain deeper insights and inform effective therapeutic strategies.

Authors

  • Aya Galal
    Systems Genomics Laboratory, American University in Cairo, New Cairo, Egypt; Institute of Global Health and Human Ecology, American University in Cairo, New Cairo, Egypt.
  • Ahmed Moustafa
    Department of Human Anatomy and Physiology, The Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa.
  • Mohamed Salama
    Institute of Global Health and Human Ecology, American University in Cairo, New Cairo, Egypt; Global Brain Health Institute (GBHI), Trinity College Dublin, Dublin 2, Ireland; Faculty of Medicine, Mansoura University, El Mansura, Egypt. Electronic address: Mohamed-Salama@aucegypt.edu.